TRBV4-1 and tuberculosis: Biased usage of TRBV4-1 has been reported for CD1b-restricted T cells from blood (22, 23) and TB pleural effusions (42), suggesting that such TCRs are clinically relevant to host response in TB disease and could be biomarkers of M. tuberculosis infection.